Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
Identifieur interne : 000938 ( PubMed/Checkpoint ); précédent : 000937; suivant : 000939Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.
Auteurs : M. Aidoo [Ghana] ; O. Nishiwaki ; H. Akari ; J A Brandful ; W. Ampofo ; M. Hayami ; N K AyisiSource :
- West African journal of medicine [ 0189-160X ]
Descripteurs français
- KwdFr :
- Anticorps anti-HTLVI (sang), Anticorps anti-VIH (sang), Ghana (épidémiologie), Humains, Surveillance de la population, Syndrome d'immunodéficience acquise (diagnostic), Syndrome d'immunodéficience acquise (immunologie), Syndrome d'immunodéficience acquise (épidémiologie), Syndrome pré-SIDA (diagnostic), Syndrome pré-SIDA (immunologie), Syndrome pré-SIDA (épidémiologie), Séroprévalence du VIH, Technique de Western, Études séroépidémiologiques.
- MESH :
- diagnostic : Syndrome d'immunodéficience acquise, Syndrome pré-SIDA.
- immunologie : Syndrome d'immunodéficience acquise, Syndrome pré-SIDA.
- sang : Anticorps anti-HTLVI, Anticorps anti-VIH.
- épidémiologie : Ghana, Syndrome d'immunodéficience acquise, Syndrome pré-SIDA.
- Humains, Surveillance de la population, Séroprévalence du VIH, Technique de Western, Études séroépidémiologiques.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- AIDS-Related Complex (diagnosis), AIDS-Related Complex (epidemiology), AIDS-Related Complex (immunology), Acquired Immunodeficiency Syndrome (diagnosis), Acquired Immunodeficiency Syndrome (epidemiology), Acquired Immunodeficiency Syndrome (immunology), Blotting, Western, Ghana (epidemiology), HIV Antibodies (blood), HIV Seroprevalence, HTLV-I Antibodies (blood), Humans, Population Surveillance, Seroepidemiologic Studies.
- MESH :
- chemical , blood : HIV Antibodies, HTLV-I Antibodies.
- geographic , epidemiology : Ghana.
- diagnosis : AIDS-Related Complex, Acquired Immunodeficiency Syndrome.
- epidemiology : AIDS-Related Complex, Acquired Immunodeficiency Syndrome.
- immunology : AIDS-Related Complex, Acquired Immunodeficiency Syndrome.
- Blotting, Western, HIV Seroprevalence, Humans, Population Surveillance, Seroepidemiologic Studies.
Abstract
Sera collection from 255 clinically diagnosed AIDS and ARC patients were analyzed for antibodies to HIV and HTLV-I by Western blot and particle agglutination methods respectively. Antibodies to HIV were detected in 37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%) of the HIV positive sera had dual reactivity to both HIV-I and HIV-2. Antibodies to HTLV-1 were more frequently detected in HIV positive sera (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to HIV were detected twice as frequently in HTLV-1 positive sera (78.6%) than in HTLV-1 negative sera (34.85%).
PubMed: 7841103
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:7841103Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.</title>
<author><name sortKey="Aidoo, M" sort="Aidoo, M" uniqKey="Aidoo M" first="M" last="Aidoo">M. Aidoo</name>
<affiliation wicri:level="4"><nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</nlm:affiliation>
<orgName type="university">Université du Ghana</orgName>
<country>Ghana</country>
<placeName><settlement type="city">Accra</settlement>
<settlement type="town">Legon (Ghana)</settlement>
<region type="region">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nishiwaki, O" sort="Nishiwaki, O" uniqKey="Nishiwaki O" first="O" last="Nishiwaki">O. Nishiwaki</name>
</author>
<author><name sortKey="Akari, H" sort="Akari, H" uniqKey="Akari H" first="H" last="Akari">H. Akari</name>
</author>
<author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name>
</author>
<author><name sortKey="Ampofo, W" sort="Ampofo, W" uniqKey="Ampofo W" first="W" last="Ampofo">W. Ampofo</name>
</author>
<author><name sortKey="Hayami, M" sort="Hayami, M" uniqKey="Hayami M" first="M" last="Hayami">M. Hayami</name>
</author>
<author><name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>1994 Jul-Sep</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:7841103</idno>
<idno type="pmid">7841103</idno>
<idno type="wicri:Area/PubMed/Corpus">000414</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000414</idno>
<idno type="wicri:Area/PubMed/Curation">000414</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000414</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000414</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000414</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.</title>
<author><name sortKey="Aidoo, M" sort="Aidoo, M" uniqKey="Aidoo M" first="M" last="Aidoo">M. Aidoo</name>
<affiliation wicri:level="4"><nlm:affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</nlm:affiliation>
<orgName type="university">Université du Ghana</orgName>
<country>Ghana</country>
<placeName><settlement type="city">Accra</settlement>
<settlement type="town">Legon (Ghana)</settlement>
<region type="region">Région du Grand Accra</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Nishiwaki, O" sort="Nishiwaki, O" uniqKey="Nishiwaki O" first="O" last="Nishiwaki">O. Nishiwaki</name>
</author>
<author><name sortKey="Akari, H" sort="Akari, H" uniqKey="Akari H" first="H" last="Akari">H. Akari</name>
</author>
<author><name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name>
</author>
<author><name sortKey="Ampofo, W" sort="Ampofo, W" uniqKey="Ampofo W" first="W" last="Ampofo">W. Ampofo</name>
</author>
<author><name sortKey="Hayami, M" sort="Hayami, M" uniqKey="Hayami M" first="M" last="Hayami">M. Hayami</name>
</author>
<author><name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name>
</author>
</analytic>
<series><title level="j">West African journal of medicine</title>
<idno type="ISSN">0189-160X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS-Related Complex (diagnosis)</term>
<term>AIDS-Related Complex (epidemiology)</term>
<term>AIDS-Related Complex (immunology)</term>
<term>Acquired Immunodeficiency Syndrome (diagnosis)</term>
<term>Acquired Immunodeficiency Syndrome (epidemiology)</term>
<term>Acquired Immunodeficiency Syndrome (immunology)</term>
<term>Blotting, Western</term>
<term>Ghana (epidemiology)</term>
<term>HIV Antibodies (blood)</term>
<term>HIV Seroprevalence</term>
<term>HTLV-I Antibodies (blood)</term>
<term>Humans</term>
<term>Population Surveillance</term>
<term>Seroepidemiologic Studies</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps anti-HTLVI (sang)</term>
<term>Anticorps anti-VIH (sang)</term>
<term>Ghana (épidémiologie)</term>
<term>Humains</term>
<term>Surveillance de la population</term>
<term>Syndrome d'immunodéficience acquise (diagnostic)</term>
<term>Syndrome d'immunodéficience acquise (immunologie)</term>
<term>Syndrome d'immunodéficience acquise (épidémiologie)</term>
<term>Syndrome pré-SIDA (diagnostic)</term>
<term>Syndrome pré-SIDA (immunologie)</term>
<term>Syndrome pré-SIDA (épidémiologie)</term>
<term>Séroprévalence du VIH</term>
<term>Technique de Western</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>HIV Antibodies</term>
<term>HTLV-I Antibodies</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Ghana</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>AIDS-Related Complex</term>
<term>Acquired Immunodeficiency Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome d'immunodéficience acquise</term>
<term>Syndrome pré-SIDA</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>AIDS-Related Complex</term>
<term>Acquired Immunodeficiency Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Syndrome d'immunodéficience acquise</term>
<term>Syndrome pré-SIDA</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>AIDS-Related Complex</term>
<term>Acquired Immunodeficiency Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps anti-HTLVI</term>
<term>Anticorps anti-VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Ghana</term>
<term>Syndrome d'immunodéficience acquise</term>
<term>Syndrome pré-SIDA</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Blotting, Western</term>
<term>HIV Seroprevalence</term>
<term>Humans</term>
<term>Population Surveillance</term>
<term>Seroepidemiologic Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Surveillance de la population</term>
<term>Séroprévalence du VIH</term>
<term>Technique de Western</term>
<term>Études séroépidémiologiques</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sera collection from 255 clinically diagnosed AIDS and ARC patients were analyzed for antibodies to HIV and HTLV-I by Western blot and particle agglutination methods respectively. Antibodies to HIV were detected in 37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%) of the HIV positive sera had dual reactivity to both HIV-I and HIV-2. Antibodies to HTLV-1 were more frequently detected in HIV positive sera (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to HIV were detected twice as frequently in HTLV-1 positive sera (78.6%) than in HTLV-1 negative sera (34.85%).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">7841103</PMID>
<DateCreated><Year>1995</Year>
<Month>03</Month>
<Day>08</Day>
</DateCreated>
<DateCompleted><Year>1995</Year>
<Month>03</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0189-160X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>13</Volume>
<Issue>3</Issue>
<PubDate><MedlineDate>1994 Jul-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>West African journal of medicine</Title>
<ISOAbbreviation>West Afr J Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients.</ArticleTitle>
<Pagination><MedlinePgn>150-1</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Sera collection from 255 clinically diagnosed AIDS and ARC patients were analyzed for antibodies to HIV and HTLV-I by Western blot and particle agglutination methods respectively. Antibodies to HIV were detected in 37.3% of the sera collected as compared to 5.5% for HTLV-I. Most (95%) of the HIV positive sera had dual reactivity to both HIV-I and HIV-2. Antibodies to HTLV-1 were more frequently detected in HIV positive sera (11.58%) than in HIV negative sera (1.88%). Conversely, antibodies to HIV were detected twice as frequently in HTLV-1 positive sera (78.6%) than in HTLV-1 negative sera (34.85%).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aidoo</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nishiwaki</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Author>
<Author ValidYN="Y"><LastName>Akari</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Brandful</LastName>
<ForeName>J A</ForeName>
<Initials>JA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ampofo</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hayami</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ayisi</LastName>
<ForeName>N K</ForeName>
<Initials>NK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Nigeria</Country>
<MedlineTA>West Afr J Med</MedlineTA>
<NlmUniqueID>8301891</NlmUniqueID>
<ISSNLinking>0189-160X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015483">HIV Antibodies</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015481">HTLV-I Antibodies</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000386" MajorTopicYN="N">AIDS-Related Complex</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005869" MajorTopicYN="N" Type="Geographic">Ghana</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015483" MajorTopicYN="N">HIV Antibodies</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015528" MajorTopicYN="N">HIV Seroprevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015481" MajorTopicYN="N">HTLV-I Antibodies</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1994</Year>
<Month>7</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1994</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1994</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">7841103</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Ghana</li>
</country>
<region><li>Région du Grand Accra</li>
</region>
<settlement><li>Accra</li>
<li>Legon (Ghana)</li>
</settlement>
<orgName><li>Université du Ghana</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Akari, H" sort="Akari, H" uniqKey="Akari H" first="H" last="Akari">H. Akari</name>
<name sortKey="Ampofo, W" sort="Ampofo, W" uniqKey="Ampofo W" first="W" last="Ampofo">W. Ampofo</name>
<name sortKey="Ayisi, N K" sort="Ayisi, N K" uniqKey="Ayisi N" first="N K" last="Ayisi">N K Ayisi</name>
<name sortKey="Brandful, J A" sort="Brandful, J A" uniqKey="Brandful J" first="J A" last="Brandful">J A Brandful</name>
<name sortKey="Hayami, M" sort="Hayami, M" uniqKey="Hayami M" first="M" last="Hayami">M. Hayami</name>
<name sortKey="Nishiwaki, O" sort="Nishiwaki, O" uniqKey="Nishiwaki O" first="O" last="Nishiwaki">O. Nishiwaki</name>
</noCountry>
<country name="Ghana"><region name="Région du Grand Accra"><name sortKey="Aidoo, M" sort="Aidoo, M" uniqKey="Aidoo M" first="M" last="Aidoo">M. Aidoo</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000938 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000938 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= SidaGhanaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:7841103 |texte= Differential reactivities of antibodies to HIV and HTLV-I in sera of suspected AIDS and ARC patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:7841103" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SidaGhanaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |